In the present study, we found that empagliflozin treatment inhibited AGEs, RAGE, NADPH oxidase-derived ROS generation, and inflammatory reactions in the adipose tissues of db/db mice in association with restoration of adiponectin expression levels and improvement of insulin resistance. This evidence concerns the gene FMO5 and Insulin resistance.